申请人:PRINCIPIA BIOPHARMA, INC.
公开号:US20160368908A1
公开(公告)日:2016-12-22
The present disclosure is directed to certain inhibitors of RLK and ITK of formula (I), pharmaceutical compositions comprising such compounds, and method of treating diseases mediated by inhibition of RLK and ITK.